FENC
Fennec Pharmaceuticals Inc
10.40$
+0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +41.2% | +157.6% | -8.7% | -6.7% | -23.7% | +3.2% | -3.3% | +9.8% | +43.2% | +1.8% | +5.5% | |
| – | +41.8% | +153.8% | -8.8% | -6.8% | -23.9% | -2.6% | -5.1% | +12.9% | +45.5% | -0.2% | +8.4% | |
| – | +7.0% | +285.7% | -15.9% | -6.4% | -33.9% | -14.9% | -17.5% | +17.3% | +67.6% | +9.2% | +2.7% | |
| – | +7.0% | +285.7% | -15.9% | -6.4% | -33.9% | -14.9% | -17.5% | +17.3% | +67.6% | +9.2% | +2.7% | |
| – | +94.8% | +16.6% | +19.8% | +4.8% | -0.2% | +19.9% | +13.3% | +10.5% | +20.0% | -19.2% | +24.0% | |
| – | +22.8% | -4.3% | +3.9% | -47.5% | -5.8% | +32.5% | +56.8% | +12.5% | -36.8% | +18.6% | +27.9% | |
| – | +30.2% | +72.0% | -2.5% | -0.7% | -20.7% | +2.9% | +0.1% | +2.7% | -34.7% | -2.7% | -2.4% | |
| – | +93.0% | +30.2% | -21.2% | -4.1% | -6.9% | +21.0% | +0.5% | +16.7% | +7.2% | -8.9% | +29.3% | |
| – | +0.0% | -19.0% | -29.4% | -41.7% | -71.4% | – | – | – | – | – | – | |
| – | +28.5% | +37.7% | -14.5% | -13.0% | -16.2% | +62.9% | +12.5% | -1.3% | -21.0% | +35.5% | -12.2% | |
| – | +20.6% | +1.4% | +1.4% | +1.0% | -39.7% | +0.1% | +0.1% | +0.1% | – | – | – | |
| – | – | – | -145.0% | – | – | – | – | – | – | +6.2% | +12.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.9% | +15.9% | -12.2% | +0.3% | +0.3% | +0.4% | +0.3% | +0.8% | +11.8% | +14.0% | +2.5% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.